Literature DB >> 9016876

Estrogen protects lenses against cataract induced by transforming growth factor-beta (TGFbeta).

A M Hales1, C G Chamberlain, C R Murphy, J W McAvoy.   

Abstract

Cataract, already a major cause of visual impairment and blindness, is likely to become an increasing problem as the world population ages. In a previous study, we showed that transforming growth factor-beta (TGFP) induces rat lenses in culture to develop opacities and other changes that have many features of human subcapsular cataracts. Here we show that estrogen protects against cataract. Lenses from female rats are more resistant to TGFbeta-induced cataract than those from males. Furthermore, lenses from ovariectomized females show increased sensitivity to the damaging effects of TGFbeta and estrogen replacement in vivo, or exposure to estrogen in vitro, restores resistance. Sex-dependent and estrogen-related differences in susceptibility to cataract formation, consistent with a protective role for estrogen, have been noted in some epidemiological studies. The present study in the rat indicates that estrogen provides protection against cataract by countering the damaging effects of TGFbeP. It also adds to an increasing body of evidence that hormone replacement therapy protects postmenopausal women against various diseases.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9016876      PMCID: PMC2196117          DOI: 10.1084/jem.185.2.273

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  46 in total

1.  Age-related decline of plasma bioavailable testosterone in adult men.

Authors:  K Nahoul; M Roger
Journal:  J Steroid Biochem       Date:  1990-02       Impact factor: 4.292

2.  Pathogenesis of posterior capsular opacification. Part II: Histopathological and in vitro culture findings.

Authors:  R Frezzotti; A Caporossi; D Mastrangelo; T Hadjistilianou; P Tosi; M Cintorino; C Minacci
Journal:  J Cataract Refract Surg       Date:  1990-05       Impact factor: 3.351

3.  Intraocular pressure and outflow facility. Effect of estrogen and combined estrogen-progestin treatment in normal human eyes.

Authors:  G Treister; S Mannor
Journal:  Arch Ophthalmol       Date:  1970-03

4.  [Pathologic cataract due to ovarian failure].

Authors:  P Cernea; F Ignat; D Dănciulescu
Journal:  Rev Chir Oncol Radiol O R L Oftalmol Stomatol Ser Oftalmol       Date:  1989 Jul-Sep

5.  Cataract extraction. Risk factors in a health maintenance organization population under 60 years of age.

Authors:  I R Schwab; M A Armstrong; G D Friedman; I G Wong; A C Carpentieri; C R Dawson
Journal:  Arch Ophthalmol       Date:  1988-08

6.  Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye.

Authors:  T B Connor; A B Roberts; M B Sporn; D Danielpour; L L Dart; R G Michels; S de Bustros; C Enger; H Kato; M Lansing
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

7.  Aqueous humor contains transforming growth factor-beta and a small (less than 3500 daltons) inhibitor of thymocyte proliferation.

Authors:  R D Granstein; R Staszewski; T L Knisely; E Zeira; R Nazareno; M Latina; D M Albert
Journal:  J Immunol       Date:  1990-04-15       Impact factor: 5.422

8.  Appearance of alpha-smooth muscle actin in human eye lens cells of anterior capsular cataract and in cultured bovine lens-forming cells.

Authors:  A Schmitt-Gräff; H Pau; R Spahr; H M Piper; O Skalli; G Gabbiani
Journal:  Differentiation       Date:  1990-04       Impact factor: 3.880

9.  Low mature TGF-beta 2 levels in aqueous humor during uveitis.

Authors:  J H de Boer; J Limpens; S Orengo-Nania; P T de Jong; E La Heij; A Kijlstra
Journal:  Invest Ophthalmol Vis Sci       Date:  1994-09       Impact factor: 4.799

10.  Fibroblast growth factor (FGF) induces different responses in lens epithelial cells depending on its concentration.

Authors:  J W McAvoy; C G Chamberlain
Journal:  Development       Date:  1989-10       Impact factor: 6.868

View more
  21 in total

Review 1.  The selective oestrogen receptor modulation: evolution and clinical applications.

Authors:  D W Purdie; S A Beardsworth
Journal:  Br J Clin Pharmacol       Date:  1999-12       Impact factor: 4.335

Review 2.  The aging human lens: structure, growth, and physiological behaviour.

Authors:  G Duncan; I M Wormstone; P D Davies
Journal:  Br J Ophthalmol       Date:  1997-10       Impact factor: 4.638

Review 3.  Can drugs or micronutrients prevent cataract?

Authors:  J J Harding
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

4.  TGFbeta induces morphological and molecular changes similar to human anterior subcapsular cataract.

Authors:  Frank J Lovicu; Mark W Schulz; Angela M Hales; Lisa N Vincent; Paul A Overbeek; Coral G Chamberlain; John W McAvoy
Journal:  Br J Ophthalmol       Date:  2002-02       Impact factor: 4.638

5.  Effect of estrogen replacement therapy on lens epithelial cell apoptosis in an experimental rat model.

Authors:  Fatih Ozcura; Sema Oruç Dündar; Emel Dikicioğlu Cetin; Nahit Beder; Mehmet Dündar
Journal:  Int Ophthalmol       Date:  2009-12-05       Impact factor: 2.031

6.  Regulation of lens gap junctions by Transforming Growth Factor beta.

Authors:  Bruce A Boswell; Judy K VanSlyke; Linda S Musil
Journal:  Mol Biol Cell       Date:  2010-03-31       Impact factor: 4.138

7.  Expression of transforming growth factor-beta in cultured normal human lens epithelia cells.

Authors:  Yukan Huang; Houren Wei
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2004

8.  Estrogen protects against radiation-induced cataractogenesis.

Authors:  Joseph R Dynlacht; Shailaja Valluri; Jennifer Lopez; Falon Greer; Colleen Desrosiers; Andrea Caperell-Grant; Marc S Mendonca; Robert M Bigsby
Journal:  Radiat Res       Date:  2008-12       Impact factor: 2.841

9.  An estrogen receptor repressor induces cataract formation in transgenic mice.

Authors:  Vicki L Davis; Chi-Chao Chan; Timothy J Schoen; John F Couse; Gerald J Chader; Kenneth S Korach
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-24       Impact factor: 11.205

10.  Prevention of posterior capsular opacification through cyclooxygenase-2 inhibition.

Authors:  Heather L Chandler; Curtis A Barden; Ping Lu; Donna F Kusewitt; Carmen M H Colitz
Journal:  Mol Vis       Date:  2007-04-30       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.